Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM3KZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,244
Award facts
- Contract value 100% obligated
- $37,243.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,243.86 on January 29, 2026, for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price, non-set-aside contract is funded by the Defense Logistics Agency (DLA) and is scheduled for completion by February 20, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle that serves as the primary mechanism for delivering pharmaceutical products and medical supplies to support military healthcare programs globally through December 2031.
Tagrisso (osimertinib) is an oncology medication used for the treatment of certain non-small cell lung cancers, reflecting the pharmaceutical distributor's critical role in supplying specialized medications across multiple therapeutic domains to federal healthcare systems. The delivery order aligns with DLA Troop Support Medical's mission to provide comprehensive pharmaceutical support to military treatment facilities, the Defense Health Agency, and other government healthcare institutions. AmerisourceBergen's consistent selection for such awards demonstrates its established capability to meet federal procurement requirements through competitive bidding and deliver essential medical commodities efficiently across the global military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FM3KZ?
SPE2DR26FM3KZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FM3KZ worth?
The government has obligated $37,244 on SPE2DR26FM3KZ.
Is contract SPE2DR26FM3KZ an order under another contract?
Yes. SPE2DR26FM3KZ is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3KZ competed?
The extent of competition for SPE2DR26FM3KZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award